About Maastricht Radiation Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Maastricht Radiation Oncology
17
Varian, a Siemens Healthineers Company
1
Clinical Trials at Maastricht Radiation Oncology
During the past decade, Maastricht Radiation Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer
2006-09-01
2018-12-01
Completed
44
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
2007-03-01
2015-12-01
Completed
103
Positron Emission Tomography-Computed Tomography (PET-CT) High-grade Glioma
2008-06-01
2010-06-01
Terminated
10
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
2009-03-01
2013-01-01
Completed
6
Quality of Life in Patients Treated for Head and Neck Cancer
2009-06-01
2010-04-01
Completed
456
Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
2013-09-01
2016-06-01
Terminated
5
Biobank Carcinoma: Storing Blood and Protein of Patients With Cancer
2003-01-01
2025-01-01
Recruiting
10,000
Re-irradiation of High Grade Gliomas: a Quality of Life Study
2013-03-01
2015-09-01
Withdrawn
0
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Maastricht Radiation Oncology"
#1 collaborator was "Maastricht University Medical Center" with 7 trials as a collaborator, "University Medical Center Groningen" with 2 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator and "Academisch Ziekenhuis Maastricht" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Maastricht Radiation Oncology
According to Clinical.Site data, the most researched conditions in "Maastricht Radiation Oncology" are
"Breast Cancer" (3 trials), "Glioblastoma" (2 trials), "Glioblastoma Multiforme" (2 trials), "Head and Neck Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Maastricht Radiation Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Maastricht Radiation Oncology
Most popular intervention types in "Maastricht Radiation Oncology" are "Drug" (5 trials), "Other" (5 trials), "Radiation" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "CBCT imaging" (1 trials), "Chloroquine" (1 trials), "Chloroquine, A-CQ 100" (1 trials), "Controlled oral word association test (COWA)" (1 trials) and "EORTC QLQ- FA13" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Maastricht Radiation Oncology
The vast majority of trials in "Maastricht Radiation Oncology" are
17 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Maastricht Radiation Oncology
Currently, there are NaN active trials in "Maastricht Radiation Oncology".
1 are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Maastricht Radiation Oncology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Maastricht Radiation Oncology, 4 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".